FDA Inspection 664690 — Weill Cornell Med College IRB

Weill Cornell Med College IRB — FEI 2431284

The FDA completed an inspection of Weill Cornell Med College IRB on May 25, 2010 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 25, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

IRB